Mashayekhi et al. [51] found the serum level of IGF-1 and IGFBPs were higher in patients affected by Parkinson disease compared to controls, but the significance of these data in the pathophysiology of the disease remains unexplained. Here, IGF1 is linked to Parkinson disease.